Survey on attitudes around dementia now open

15 April 2019 – ADI's survey on attitudes around dementia is now open and we want to hear what YOU think. The survey will form the basis for the World Alzheimer Report 2019, to be released in September. It will only take around 10 minutes of your time but completing it will benefit people with dementia all over the world. [Read more] 

Queen Silvia of Sweden awarded for becoming Global Ambassador

3 April 2019 – ADI's Chief Executive Paola Barbarino presented Her Majesty Queen Silvia of Sweden with an award for becoming ADI’s Global Ambassador at the Jubilee event for the Queen Silvia Nursing Award at the Royal Palace of Stockholm. [read more]

Biogen and Eisai remain committed after discontinuation of ENGAGE and EMERGE programmes

22 March 2019 – Pharmaceutical companies Biogen and Eisai have announced the discontinuation of two Phase 3 trials of aducanumab. The decision came after analysis by an independent monitoring committee indicated the trials were unlikely to succeed. Biogen and Eisai will continue to investigate other treatments for Alzheimer’s disease, including anti-amyloid treatment BAN2401. [read more]

Global Perspective Newsletter for February 2019

The February 2019 edition of our Global Perspective Newsletter is now available. Read the latest news from ADI, our partners and member associations, including updates from the WHO Executive Board; the Korean National Institute (KNID)'s symposium; Dementia Alliance International, and much more. [read it now]

Syndicate content